CNTB · Connect Biopharma Holdings Ltd · Documents
$0.87
+0.03 (+3.62%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2022 earnings call transcript
Market Cap
$53.06M
Shares
62.97M
Volume · Oct 27
570.81K
Avg daily vol (3M)
3.89M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Connect Biopharma reported Phase 2 results for rademikibart in COPD: treatment failure fell 81%, moderate-to-severe exacerbations fell 85%, and ED visits or hospital admissions fell 100% through Week 4 versus placebo; it will seek FDA input on Phase 3. | 2026-09-30 | — | |
| 8-K | — | 2026-09-15 | — | |
| 10-Q | — | 2026-08-12 | 2026-06-30 | |
| 8-K | — | 2026-08-12 | — | |
| Investor Event Transcript | — | 2026-05-19 | 2026-06-30 | |
| F-3 | — | 2026-05-15 | — | |
| 10-Q | — | 2026-05-12 | 2026-03-31 | |
| 8-K | — | 2026-05-12 | — | |
| 8-K | — | 2026-04-23 | — | |
| 10-K | — | 2026-03-31 | 2025-12-31 | |
| 8-K | — | 2026-03-31 | — | |
| 8-K | — | 2026-03-30 | 2026-03-29 | |
| Investor Event Transcript | — | 2026-03-30 | 2026-03-31 | |
| 8-K | — | 2025-12-23 | 2025-12-17 | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| 8-K | — | 2025-11-12 | — | |
| 8-K | — | 2025-09-16 | — | |
| 8-K | — | 2025-08-13 | — | |
| 10-Q | — | 2025-08-13 | 2025-06-30 | |
| 8-K | — | 2025-07-22 | — | |
| 8-K | — | 2025-07-21 | 2025-07-18 | |
| 8-K | — | 2025-07-17 | 2025-07-16 | |
| 8-K | — | 2025-07-09 | — | |
| F-3 | — | 2025-06-10 | — | |
| 10-Q | — | 2025-05-15 | 2025-03-31 | |
| 8-K | — | 2025-05-15 | — | |
| 8-K | — | 2025-05-14 | — | |
| 8-K | — | 2025-05-13 | — | |
| 8-K | — | 2025-04-01 | — | |
| 8-K | — | 2025-03-31 | — | |
| 10-K | — | 2025-03-31 | 2024-12-31 | |
| 6-K | — | 2025-03-28 | — | |
| 6-K | — | 2024-12-23 | 2024-12-10 | |
| 6-K | — | 2024-09-06 | — | |
| 6-K | — | 2024-09-05 | 2024-06-30 | |
| 6-K | — | 2024-08-02 | — | |
| 6-K | — | 2024-06-12 | — | |
| 6-K | — | 2024-04-16 | — | |
| 20-F | — | 2024-04-16 | 2023-12-31 | |
| 6-K | — | 2024-02-12 | — | |
| 6-K | — | 2023-12-12 | — | |
| 6-K | — | 2023-11-21 | — | |
| 6-K | — | 2023-11-01 | — | |
| 6-K | — | 2023-10-20 | — | |
| 6-K | — | 2023-09-12 | 2023-06-30 | |
| 6-K | — | 2023-09-12 | — | |
| 6-K | — | 2023-07-14 | — | |
| 6-K | — | 2023-06-23 | — | |
| 6-K | — | 2023-06-05 | — | |
| 6-K | — | 2023-06-01 | — |
Showing 1–50 of 90 filings